Health Catalyst announced that the Able Health Registry has received Quality Payment Program, or QPP, Qualified Registry approval for the 2024 performance year by the Centers for Medicare and Medicaid Services, or CMS. According to CMS, the QPP program “aims to improve the quality and safety of care for all individuals and to reduce the administrative burden on clinicians, allowing more time to focus on person-centered care and improving health outcomes.” The Qualified Registry designation recognizes that Health Catalyst is an approved vendor to calculate and report QPP program measures.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HCAT:
- Health Catalyst to Announce Fourth Quarter and Full Year 2023 Operating Results and Host Conference Call on Thursday, February 22, 2024
- Tesla downgraded, Coinbase upgraded: Wall Street’s top analyst calls
- Health Catalyst upgraded to Buy from Neutral at Guggenheim
- Health Catalyst price target raised to $17 from $12 at Piper Sandler
- ‘Profitability Is the Key’: Barclays Says These 3 Health Tech Stocks Are Poised for Growth
